TB-500: The Healing Peptide Guide — Benefits, Dosing & How It Works

What Is TB-500?

TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide found in virtually every cell of the human body. Thymosin Beta-4 is one of the most abundant peptides in mammals — it plays a central role in tissue repair, inflammation regulation, cell migration, and new blood vessel formation. The synthetic version, TB-500, reproduces the most biologically active portion of the full protein for use as a therapeutic peptide.

How TB-500 Works

TB-500 works primarily by upregulating actin — a protein that forms the structural scaffolding inside cells and is essential for cell movement and healing. When tissue is injured, cells need to migrate to the damage site and proliferate to repair it. TB-500 accelerates this process by promoting cell migration, stimulating angiogenesis (new blood vessel formation), and reducing acute and chronic inflammation.

• ✓Upregulates actin expression — the key protein for cellular movement and structural repair
• ✓Promotes angiogenesis — new capillary growth improves oxygen and nutrient delivery to injured tissue
• ✓Anti-inflammatory — downregulates inflammatory cytokines including IL-1β and TNF-α
• ✓Stem cell activation — mobilizes stem cells from bone marrow to injured tissue sites
• ✓Cardiac repair — studies show regeneration of heart muscle cells after ischemic injury
• ✓Neurological — promotes neuronal survival and remyelination in CNS injury models

What TB-500 Is Used For

TB-500 has one of the broadest tissue-repair applications of any available peptide. Its ability to accelerate healing without tissue-type specificity makes it valuable across a wide range of clinical presentations.

• ✓Musculoskeletal injuries — tendon, ligament, and muscle tears; rotator cuff; Achilles; MCL/ACL
• ✓Chronic tendinopathy — conditions that have not responded to standard physical therapy
• ✓Post-surgical recovery — accelerates healing of surgical incisions and repaired tissue
• ✓Cardiovascular — being studied for cardiac repair following heart attack
• ✓Neurological recovery — traumatic brain injury, peripheral nerve damage, spinal cord injury research
• ✓Eye injuries — corneal wound healing, retinal repair
• ✓Hair growth — promotes follicle proliferation in alopecia models

TB-500 vs BPC-157: What Is the Difference?

TB-500 and BPC-157 are both healing peptides and are frequently stacked together in what practitioners call the "Wolverine stack," but they work through different mechanisms and have different tissue-type strengths.

• ✓TB-500: Systemic — travels throughout the body via bloodstream; particularly strong for musculoskeletal, cardiac, and neurological tissue
• ✓BPC-157: More locally active when injected; particularly strong for gut healing, tendon-to-bone insertion points, and nerve repair
• ✓TB-500: Works via actin upregulation and stem cell mobilization
• ✓BPC-157: Works via nitric oxide signaling and growth factor receptor upregulation
• ✓Stacked together: The two peptides complement each other — BPC-157 provides local precision, TB-500 provides systemic reach
• ✓Stacking protocol: 250–500mcg BPC-157 daily + TB-500 2–5mg 2x/week is a common combination

Dosing Protocols

TB-500 is administered subcutaneously and is typically dosed less frequently than BPC-157 due to its longer half-life and systemic distribution. Dosing is typically higher than BPC-157 because TB-500 distributes throughout the body rather than concentrating locally.

• ✓Loading phase: 4–6mg per week (split into 2 injections of 2–3mg) for the first 4–6 weeks
• ✓Maintenance phase: 2–6mg every 2 weeks once injury healing is well underway
• ✓Acute injury protocol: May use loading phase doses for the full 8–12 weeks
• ✓Reconstitution: Typically reconstituted with bacteriostatic water to 1–2mg/mL
• ✓Injection site: Subcutaneous injection, near the injury site when practical but systemic distribution means proximity matters less than with BPC-157
• ✓Cycle length: 8–16 weeks depending on injury severity, followed by a 4–6 week break

Safety Profile and Side Effects

TB-500 has a strong safety profile in the published research and in extensive anecdotal clinical use. No significant toxicity has been observed even at high doses in animal models. Because TB-500 promotes angiogenesis and potentially stem cell migration, the same caution as with BPC-157 applies: it should be avoided by anyone with active cancer or a recent cancer history, as promoting new blood vessel growth near a tumor could be counterproductive.

• ✓Most commonly reported: mild injection site irritation, temporary lethargy in first 1–2 days
• ✓Rare reports: temporary worsening of inflammation in the first week (likely a healing response)
• ✓Avoid in: active cancer, recent cancer history, pregnancy
• ✓Not a steroid or hormone — does not affect the HPTA axis, does not require PCT
• ✓Not a WADA-prohibited substance in its natural form, but TB-500 is on the WADA prohibited list — relevant for competitive athletes

What to Expect: Timeline

TB-500 typically produces noticeable results within 2–3 weeks for most acute injuries. The systemic nature of the peptide means that improvements are sometimes noticed in tissues beyond the primary injury site — a common report is reduced inflammation throughout the body, improved energy, and better recovery from training alongside the targeted healing effect. Full protocol results are usually evident by weeks 8–12.